| Authors: |
Timóteo R; School of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisboa, Portugal; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Laborde A; IT People, Praça Alvalade 7, 1700-345, Lisboa, Portugal., Vaz B; IT People, Praça Alvalade 7, 1700-345, Lisboa, Portugal., Loução N; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Forghani Y; School of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisboa, Portugal; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Cardoso A; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Correia M; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Santinha J; School of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisboa, Portugal; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal., Simões Lopes D; ITI/LARSyS, Av. Prof. Gama Pinto 2, 1649-003, Lisboa, Portugal; Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisboa, Portugal., Marques T; School of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisboa, Portugal; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal. Electronic address: tiago.marques@research.fchampalimaud.org., Gouveia P; School of Medicine, University of Lisbon, Av. Prof. Egas Moniz MB, 1649-028, Lisboa, Portugal; Breast Cancer Research Program, Champalimaud Foundation, Av Brasília, 1400-038, Lisboa, Portugal. Electronic address: pedro.gouveia@fundacaochampalimaud.pt. |